COLL
Price
$25.59Alerts
Change
+$0.16 (+0.63%)
Updated
Nov 17, 04:59 PM (EDT)
Capitalization
788.17M
100 days until earnings call
Intraday BUY SELL Signals
XERS
Price
$16.78Alerts
Change
+$0.08 (+0.48%)
Updated
Nov 17, 04:59 PM (EDT)
Capitalization
2.77B
113 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COLL vs XERS

COLL vs XERS Comparison Chart in %
View a ticker or compare two or three
VS
COLL vs. XERS commentary
Nov 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COLL is a StrongBuy and XERS is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for COLL with price predictions
Nov 16, 2026

COLL in upward trend: 10-day moving average broke above 50-day moving average on November 02, 2026

The 10-day moving average for COLL crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on COLL as a result. In 67 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

COLL moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where COLL advanced for three days, in 224 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

The Aroon Indicator entered an Uptrend today. In 174 of 230 cases where COLL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.

Bearish Trend Analysis

The 10-day RSI Indicator for COLL moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 30 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 59 cases where COLL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COLL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

COLL broke above its upper Bollinger Band on November 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 50 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.527) is normal, around the industry mean (6.379). P/E Ratio (16.033) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.664) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (0.995) is also within normal values, averaging (183.387).

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. COLL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 88 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COLL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for XERS with price predictions
Nov 16, 2026

XERS in +0.30% Uptrend, growing for three consecutive days on November 16, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where XERS advanced for three days, in 222 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 05, 2026. You may want to consider a long position or call options on XERS as a result. In 71 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.

The Moving Average Convergence Divergence (MACD) for XERS just turned positive on November 05, 2026. Looking at past instances where XERS's MACD turned positive, the stock continued to rise in 35 of 42 cases over the following month. The odds of a continued upward trend are 83%.

The Aroon Indicator entered an Uptrend today. In 191 of 232 cases where XERS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XERS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

XERS broke above its upper Bollinger Band on November 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: XERS's P/B Ratio (-284.700) is very low in comparison to the industry average of (6.379). XERS has a moderately low P/E Ratio (-152.000) as compared to the industry average of (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (4.196) is also within normal values, averaging (183.387).

The Tickeron Profit vs. Risk Rating rating for this company is 5 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. XERS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
COLL vs XERS: Fundamental Ratings
COLL
XERS
OUTLOOK RATING
1..100
3147
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
1
Undervalued
PROFIT vs RISK RATING
1..100
885
SMR RATING
1..100
50100
PRICE GROWTH RATING
1..100
6034
P/E GROWTH RATING
1..100
8799
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XERS's Valuation (1) in the Pharmaceuticals Major industry is somewhat better than the same rating for COLL (58) in the Pharmaceuticals Other industry. This means that XERS’s stock grew somewhat faster than COLL’s over the last 12 months.

XERS's Profit vs Risk Rating (5) in the Pharmaceuticals Major industry is significantly better than the same rating for COLL (88) in the Pharmaceuticals Other industry. This means that XERS’s stock grew significantly faster than COLL’s over the last 12 months.

COLL's SMR Rating (50) in the Pharmaceuticals Other industry is somewhat better than the same rating for XERS (100) in the Pharmaceuticals Major industry. This means that COLL’s stock grew somewhat faster than XERS’s over the last 12 months.

XERS's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as COLL (60) in the Pharmaceuticals Other industry. This means that XERS’s stock grew similarly to COLL’s over the last 12 months.

COLL's P/E Growth Rating (87) in the Pharmaceuticals Other industry is in the same range as XERS (99) in the Pharmaceuticals Major industry. This means that COLL’s stock grew similarly to XERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COLLXERS
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 5 days ago
71%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 16 days ago
69%
Bearish Trend 16 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
COMPARISON
Comparison
Nov 17, 2026
Stock price -- (COLL: $25.43 vs. XERS: $16.70)
Brand notoriety: COLL and XERS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: COLL: 77% vs. XERS: 77%
Market capitalization -- COLL: $788.17M vs. XERS: $2.77B
COLL [@Pharmaceuticals: Generic] is valued at $788.17M. XERS’s [@Pharmaceuticals: Generic] market capitalization is $2.77B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COLL’s FA Score shows that 0 FA rating(s) are green while XERS’s FA Score has 2 green FA rating(s).

  • COLL’s FA Score: 0 green, 5 red.
  • XERS’s FA Score: 2 green, 3 red.
According to our system of comparison, XERS is a better buy in the long-term than COLL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COLL’s TA Score shows that 5 TA indicator(s) are bullish while XERS’s TA Score has 4 bullish TA indicator(s).

  • COLL’s TA Score: 5 bullish, 4 bearish.
  • XERS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, COLL is a better buy in the short-term than XERS.

Price Growth

COLL (@Pharmaceuticals: Generic) experienced а +2.91% price change this week, while XERS (@Pharmaceuticals: Generic) price change was +5.30% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.48%. For the same industry, the average monthly price growth was -6.84%, and the average quarterly price growth was -7.77%.

Reported Earning Dates

COLL is expected to report earnings on Feb 25, 2027.

XERS is expected to report earnings on Mar 10, 2027.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.48% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
Interact to see
Advertisement

COLL and

Correlation & Price change

A.I.dvisor indicates that over the last year, COLL has been loosely correlated with VTRS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COLL jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COLL
1D Price
Change %
COLL100%
+0.43%
VTRS - COLL
42%
Loosely correlated
-0.38%
EBS - COLL
40%
Loosely correlated
+0.35%
XERS - COLL
37%
Loosely correlated
+0.24%
AMPH - COLL
35%
Loosely correlated
-0.68%
AMRX - COLL
34%
Loosely correlated
-0.70%
More

XERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, XERS has been loosely correlated with MIRM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if XERS jumps, then MIRM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XERS
1D Price
Change %
XERS100%
+0.24%
MIRM - XERS
45%
Loosely correlated
-2.56%
KROS - XERS
38%
Loosely correlated
-2.62%
AXON - XERS
37%
Loosely correlated
-2.85%
REPL - XERS
36%
Loosely correlated
-2.19%
COLL - XERS
36%
Loosely correlated
+0.43%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AMZO13.120.81
+6.58%
Tradr 2X Short AMZN Daily ETF (AMZO)
USOI42.20-0.91
-2.12%
UBS AG ETRACS Crude Oil Shares Covered Call ETNs due April 24, 2037 (USOI)
IDVO38.56-1.09
-2.75%
Amplify CWP International Enhanced Dividend Income ETF (IDVO)
TEMR25.05-0.83
-3.20%
T. Rowe Price Emerging Markets Equity Research ETF (TEMR)
FOTO12.48-1.01
-7.45%
Tuttle Capital Pure Play Photonics ETF (FOTO)